IMP2 is a critical regulator of glycolysis in colorectal cancer, driving tumor progression by stabilizing m6A-modified mRNAs of key glycolytic enzymes, hexokinase 2 (encoding HK2) and SLC2A1 (encoding GLUT1) [16]. The gene discussed is HK2; the disease is neoplasm.